RZLT

Rezolute, Inc. - Common Stock (NV) (RZLT)

About Rezolute, Inc. - Common Stock (NV) (RZLT)

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Details

Daily high

$3.97

Daily low

$3.56

Price at open

$3.93

52 Week High

$11.46

52 Week Low

$1.07

Market cap

383.0M

Dividend yield

Volume

1.2M

Avg. volume

1.4M

P/E ratio

-5.30

Rezolute, Inc. - Common Stock (NV) News